Showing 4,041 - 4,060 results of 12,750 for search '"therapeutics"', query time: 0.08s Refine Results
  1. 4041

    Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia by Vijay Murali Ravi Mythili, Ramya Lakshmi Rajendran, Raksa Arun, Vasanth Kanth Thasma Loganathbabu, Danyal Reyaz, ArulJothi Kandasamy Nagarajan, Byeong-Cheol Ahn, Prakash Gangadaran

    Published 2025-01-01
    “…Critical limb ischemia (CLI) poses a substantial and intricate challenge in vascular medicine, necessitating the development of innovative therapeutic strategies to address its multifaceted pathophysiology. …”
    Get full text
    Article
  2. 4042

    Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis by Fan Yang, Beibei Ni, Xiaoqi Liang, Yizhan He, Chao Yuan, Jiajie Chu, Yiju Huang, Hongyu Zhong, Li Yang, Jianxi Lu, Yan Xu, Qi Zhang, Wenjie Chen

    Published 2025-01-01
    “…Abstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. …”
    Get full text
    Article
  3. 4043
  4. 4044
  5. 4045

    A multifunctional mesoporous silica drug delivery nanosystem that ameliorates tumor hypoxia and increases radiotherapy efficacy by Yanhong Chu, LiFeng Wang, Yaohua Ke, Xiaoyu Feng, Wenmei Rao, Wei Ren, Kai Xin, Yan Wang, Lixia Yu, Baorui Liu, Qin Liu

    Published 2024-08-01
    “…These attributes collectively augmented the therapeutic efficacy of RT by alleviating hypoxia and immunosuppression. …”
    Get full text
    Article
  6. 4046

    Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases by Jiani Li, Chen Guo, Xiaofei Yang, Weinan Xie, Wenjing Mi, Chenglong Hua, Cheng Tang, Han Wang

    Published 2025-03-01
    “…This review aims to elucidate the metabolic regulation of the immune system, analyze metabolic alterations in macrophage associated with metabolic diseases, and summarize the beneficial roles of natural products in immunometabolism, providing novel insights for the prevention and therapeutic management of metabolic diseases.…”
    Get full text
    Article
  7. 4047

    The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer by J. L. Schwartz, A. N. Shajahan, R. Clarke

    Published 2011-01-01
    “…By understanding IRF1 signaling in the context of endocrine responsiveness, we may be able to develop novel therapeutic strategies and better predict how patients will respond to endocrine therapy.…”
    Get full text
    Article
  8. 4048

    Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells by Amirhosein Maharati, Yasamin Rajabloo, Meysam Moghbeli

    Published 2025-01-01
    “…However, CDDP resistance is a frequent therapeutic challenge that reduces prognosis in cancer patients. …”
    Get full text
    Article
  9. 4049

    Colon-targeted engineered postbiotics nanoparticles alleviate osteoporosis through the gut-bone axis by Tingting Yu, Rushui Bai, Zeming Wang, Yuting Qin, Jingwei Wang, Yaohua Wei, Ruifang Zhao, Guangjun Nie, Bing Han

    Published 2024-12-01
    “…Specifically, the treatment of engineered postbiotics nanoparticles can also improve the quality and quantity of bone with restoration of deteriorative mechanical properties, which indicating a therapeutic potential on fracture prevention. This study provides valuable insights into the gut-bone axis and establishes a promising and safe therapeutic strategy for osteoporosis.…”
    Get full text
    Article
  10. 4050

    Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage by Gabriela Montes-Rivera, Grissel Ríos, Luis M. Vilá

    Published 2017-01-01
    “…This case, together with other reports, suggests that rituximab is an effective therapeutic option for DAH in SLE.…”
    Get full text
    Article
  11. 4051

    Immunomodulatory Properties of HLA-G in Infectious Diseases by Laurence Amiot, Nicolas Vu, Michel Samson

    Published 2014-01-01
    “…We also discuss the cellular source of HLA-G, according to the type of infection and the potential role of HLA-G. New therapeutic approaches based on synthetic HLA-G-derived proteins or antibodies are emerging in mouse models of cancer or transplantation, and these new therapeutic tools may eventually prove useful for the treatment of infectious diseases.…”
    Get full text
    Article
  12. 4052

    Muscle Satellite Cells: Exploring the Basic Biology to Rule Them by Camila F. Almeida, Stephanie A. Fernandes, Antonio F. Ribeiro Junior, Oswaldo Keith Okamoto, Mariz Vainzof

    Published 2016-01-01
    “…Every phase of satellite cell activity is highly regulated and orchestrated by many molecules and signaling pathways; the elucidation of players and mechanisms involved in satellite cell biology is of extreme importance, being the first step to expose the crucial points that could be modulated to extract the optimal response from these cells in therapeutic strategies. Here, we review the basic aspects about satellite cells biology and briefly discuss recent findings about therapeutic attempts, trying to raise questions about how basic biology could provide a solid scaffold to more successful use of these cells in clinics.…”
    Get full text
    Article
  13. 4053

    A Case of Subacute Cutaneous Lupus Erythematosus in a Patient with Mixed Connective Tissue Disease: Successful Treatment with Plasmapheresis and Rituximab by M. Fantò, S. Salemi, F. Socciarelli, A. Bartolazzi, G. A. Natale, I. Casorelli, A. Pavan, S. Vaglio, R. Di Rosa, R. D'Amelio

    Published 2013-01-01
    “…Subsequently, the patient was treated with three cycles of therapeutic plasma exchange (TPE) followed, one month after the last TPE, by the anti-CD20 antibody Rituximab (RTX) (375 mg/m2 weekly for 4 weeks). …”
    Get full text
    Article
  14. 4054

    Malignant Pleural Effusion: Diagnosis and Management by Lucía Ferreiro, Juan Suárez-Antelo, José Manuel Álvarez-Dobaño, María E. Toubes, Vanessa Riveiro, Luis Valdés

    Published 2020-01-01
    “…Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). …”
    Get full text
    Article
  15. 4055

    Microbial boundaries in peri-implantitis: a review of pathogen-related advances by Ehab Qasim Talib, Ghada Ibrahim Taha, Dhuha Mahmood Ali, Sahar Hashim Al-Hindawi, Fadia Abd Almuhsin Al-Khayat, Israa Amer Hasan

    Published 2024-12-01
    “…It covers a range of therapeutic approaches including surgical and non-surgical techniques as well as strategies stressing host-modification and photodynamic treatment. …”
    Get full text
    Article
  16. 4056

    Comparison of steroid and platelet-rich plasma (prp) applications in the treatment of collagenase induced tendinopathy in rabbit by Nuriza Zamirbekova, Nuri Yavru

    Published 2021-06-01
    “…Rabbits were euthanized 3, 6, and 8 weeks after the therapeutic injections. The degree of histopathological degeneration of the tendons was made according to the Modified Movin scoring.…”
    Get full text
    Article
  17. 4057

    Ethnomedicinal understandings and pharmacognosy of Dischidia (Apocynaceae: Asclepiadoideae): A potential epiphytic genus by Gitartha Saikia, Nilakshee Devi

    Published 2025-02-01
    “…Till hitherto, 21 bioactive compounds have been isolated from four species of Dischidia. The therapeutic potentialities of the documented bioactive compounds are boon with 18 different kinds of healing activities with the discovery of novel chemical compounds makes Dischidia as a potential and promising epiphytic genus of the Plant Kingdom.…”
    Get full text
    Article
  18. 4058

    QSAR modeling of benzoquinone derivatives as 5-lipoxygenase inhibitors by T.K. Shameera Ahamed, Vijisha K. Rajan, K. Muraleedharan

    Published 2019-03-01
    “…This has increased the search for efficient therapeutic agents for protein 5-LOX and this process is now primarily based on QSAR. …”
    Get full text
    Article
  19. 4059

    Treatment Approaches to Speech Sound Disorders: A Scoping Review by Hafsa Noreen, Nazia Mumtaz, Ghulam Saqulain

    Published 2024-03-01
    “… Objective: The objective was to highlight and review different therapeutic approaches to cater to speech sound disorders in Pakistan. …”
    Get full text
    Article
  20. 4060

    The chemistry of gut microbiome in health and diseases by Agnes Wei Yin Lau, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Sunny Hei Wong, Vengadesh Letchumanan, Learn-Han Lee

    Published 2021-02-01
    “…With a better understanding of this relationship, we will investigate the potential methods to modify the gut flora as the background of developing therapeutic options. There are already some therapeutic options such as prebiotics, probiotics, and fecal transplantation, but their clinical use is limited and restricted. …”
    Get full text
    Article